Loading
Loading
Your feedback directly shapes Sporos.
Sign in to track your feedback history
The Department of Health and Human Services ("HHS" or "Department") herein publishes the panels of Schedule I and II drugs and biomarkers authorized for testing in Federal workplace drug testing programs. The Department has revised the drug testing panels for both urine and oral fluid, and revised required nomenclature for laboratory and Medical Review Officer Reports.
Published
Jan 16, 2025
Effective
Jul 7, 2025
Citation
90 FR 4662
Agencies
1
Full text not available in our database.
View on Federal Register →Get a plain-English explanation of what this regulation does, which agencies are responsible, and how it affects existing rules.
No document text available yet
42 CFR